Bank Of America Corp Catalent, Inc. Call Options Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $851,200 - $1.2 Million	-20,000 Reduced 50.0%	20,000 $1.13 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $1.29 Million - $1.86 Million	40,000 New	40,000 $1.8 Million
Q1 2023 May 12, 2023	SELL	$45.44 - $74.26 $1.46 Million - $2.38 Million	-32,100 Reduced 74.83%	10,800 $709,000
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $1.78 Million - $3.47 Million	42,900 New	42,900 $1.93 Million

488

161M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.8B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.